What is MapLight Therapeutics, Inc. (MPLT)?
MapLight Therapeutics, Inc. is a biotechnology company focused on the development of novel therapies for cancer treatment. The company employs a proprietary platform to identify and develop targeted therapeutics aimed at modulating the tumor microenvironment. Its research efforts concentrate on creating treatments that can enhance immune response and improve patient outcomes. The company operates within the pharmaceutical and biotechnology industry, collaborating with academic institutions and other entities to advance its pipeline. Its strategic approach involves leveraging scientific innovation to address unmet medical needs in oncology.
MapLight Therapeutics, Inc. Stock Price Today: Live Overview
The price today is shaped by the latest market moves with Strive Inc at $17.64. The price variation has been between $16.92 and $17.92, showing a daily change of 0%.
FAQ: MapLight Therapeutics, Inc. (MPLT)
What is the current price of MPLT stock?
The current market price stands at $17.64.
Does MPLT pay dividends?
MapLight Therapeutics, Inc. does not currently pay dividends.
Does MPLT have a formal corporate presence or regional headquarters in the UAE?
The company operates through partners and distributors in the UAE and does not have an official regional office or subsidiary.
What is MPLT best known for?
MapLight Therapeutics, Inc. is most famous for its innovative approaches in therapeutic development.
What assets are typically shown together with MPLT?
Commonly shown alongside MPLT: iShares Broad USD Investment Grade Corporate Bond ETF, First Trust NASDAQ Cybersecurity ETF, First Trust NASDAQ Cybersecurity ETF
Latest shares articles



